Granisetron

GRANIVIB

null
COMPOSITION
Granisetron1MG
SPECIFICATION
FORMINJECTABLE
PACKING 1’S
PACKING TYPE
MRP80

DESCRIPTION

A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic and antinauseant for cancer chemotherapy patients. [PubChem]

SIDE EFFECTS

LD50>2000 mg/kg (rat, oral)

INDICATION

For the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy (including high dose cisplatin), postoperation, and radiation (including total body irradiation and daily fractionated abdominal radiation).

Important Notice:-  The Database is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

null